{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T19:25:14Z","timestamp":1758050714405,"version":"3.44.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.cellimm.2014.11.003","type":"journal-article","created":{"date-parts":[[2014,11,11]],"date-time":"2014-11-11T16:11:42Z","timestamp":1415722302000},"page":"17-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Induction of anti-tumor immunity by dendritic cells transduced with FAT10 recombinant adenovirus in mice"],"prefix":"10.1016","volume":"293","author":[{"given":"Zhao","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dayong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wengjuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongwei","family":"Huan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2014.11.003_b0005","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000343837","article-title":"Immunotherapeutic approaches to hepatocellular carcinoma treatment","volume":"1","author":"Miamen","year":"2012","journal-title":"Liver Cancer"},{"key":"10.1016\/j.cellimm.2014.11.003_b0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-3-642-38965-8_7","article-title":"Prevention of hepatitis C virus infection and liver cancer","volume":"193","author":"Lim","year":"2014","journal-title":"Recent Results Cancer Res."},{"key":"10.1016\/j.cellimm.2014.11.003_b0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.toxlet.2013.04.004","article-title":"Diosmin abrogates chemically induced hepatocarcinogenesis via alleviation of oxidative stress, hyperproliferative and inflammatory markers in murine model","volume":"220","author":"Tahir","year":"2013","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cellimm.2014.11.003_b0020","first-page":"2361","article-title":"Prognostic factors in hepatitis C patients with a single small hepatocellular carcinoma after radiofrequency ablation","volume":"59","author":"Toshikuni","year":"2012","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.cellimm.2014.11.003_b0025","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.7314\/APJCP.2012.13.5.1771","article-title":"Recurrence after anatomic resection versus nonanatomic resection for hepatocellular carcinoma: a meta-analysis","volume":"13","author":"Ye","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.cellimm.2014.11.003_b0030","doi-asserted-by":"crossref","first-page":"e603","DOI":"10.1016\/j.ijrobp.2011.09.053","article-title":"Salvage treatment with hypofractionated radiotherapy in patients with recurrent small hepatocellular carcinoma","volume":"82","author":"Bae","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.cellimm.2014.11.003_b0035","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jamcollsurg.2006.06.016","article-title":"Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival","volume":"203","author":"Bharat","year":"2006","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.cellimm.2014.11.003_b0040","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1432-2277.2006.00279.x","article-title":"A prospective, randomized, multi-centre trial of systemic adjuvant chemotherapy versus no additional treatment in liver transplantation for hepatocellular carcinoma","volume":"19","author":"Soderdahl","year":"2006","journal-title":"Transpl. Int."},{"key":"10.1016\/j.cellimm.2014.11.003_b0045","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.transproceed.2006.01.010","article-title":"Expanded criteria for liver transplantation in patients with hepatocellular carcinoma","volume":"38","author":"Karakayali","year":"2006","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.cellimm.2014.11.003_b0050","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nchembio.2007.43","article-title":"Mechanisms, biology and inhibitors of deubiquitinating enzymes","volume":"3","author":"Love","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.cellimm.2014.11.003_b0055","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35087056","article-title":"Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin\u2013proteasome degradation","volume":"3","author":"Dai","year":"2001","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.cellimm.2014.11.003_b0060","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00001813-200007000-00001","article-title":"Proteasome inhibitors as anti-cancer agents","volume":"11","author":"Murray","year":"2000","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.cellimm.2014.11.003_b0065","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nature03588","article-title":"Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex","volume":"435","author":"Reverter","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2014.11.003_b0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0378-1119(02)00843-0","article-title":"Molecular features of human ubiquitin-like SUMO genes and their encoded proteins","volume":"296","author":"Su","year":"2002","journal-title":"Gene"},{"key":"10.1016\/j.cellimm.2014.11.003_b0075","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1006\/jmbi.1998.1839","article-title":"Structure determination of the small ubiquitin-related modifier SUMO-1","volume":"280","author":"Bayer","year":"1998","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.cellimm.2014.11.003_b0080","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/carcin\/bgt407","article-title":"FAT10, an ubiquitin-like protein, confers malignant properties in non-tumorigenic and tumorigenic cells","volume":"35","author":"Gao","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cellimm.2014.11.003_b0085","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1242\/jcs.087403","article-title":"FAT10 mediates the effect of TNF-alpha in inducing chromosomal instability","volume":"124","author":"Ren","year":"2011","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.cellimm.2014.11.003_b0090","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1747-1028-1-20","article-title":"FAT10, a gene up-regulated in various cancers, is cell-cycle regulated","volume":"1","author":"Lim","year":"2006","journal-title":"Cell Div."},{"key":"10.1016\/j.cellimm.2014.11.003_b0095","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/sj.onc.1209220","article-title":"P53 negatively regulates the expression of FAT10, a gene upregulated in various cancers","volume":"25","author":"Zhang","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.cellimm.2014.11.003_b0100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yexmp.2010.09.005","article-title":"Increased expression of FAT10 in colon benign, premalignant and malignant epithelial neoplasms","volume":"90","author":"Qing","year":"2011","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.cellimm.2014.11.003_b0105","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.1038\/onc.2008.201","article-title":"Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon","volume":"27","author":"Lukasiak","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.cellimm.2014.11.003_b0110","first-page":"190","article-title":"Accuracy of multislice computed tomography in the diagnosis of hepatocellular carcinoma in patients with cirrhosis evaluated for liver transplantation","volume":"41","author":"Haberman","year":"2011","journal-title":"Acta Gastroenterol. Latinoam."},{"key":"10.1016\/j.cellimm.2014.11.003_b0115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/10408360500410407","article-title":"The molecular diagnosis of hepatitis B virus-associated hepatocellular carcinoma","volume":"43","author":"Wong","year":"2006","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.cellimm.2014.11.003_b0120","first-page":"1278","article-title":"Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma","volume":"118","author":"Wang","year":"2005","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.cellimm.2014.11.003_b0125","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/gt.2013.28","article-title":"An armed oncolytic measles vaccine virus eliminates human hepatoma cells independently of apoptosis","volume":"20","author":"Lampe","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.cellimm.2014.11.003_b0130","doi-asserted-by":"crossref","first-page":"236","DOI":"10.18632\/oncotarget.466","article-title":"Targeted therapy for hepatocellular carcinoma: novel agents on the horizon","volume":"3","author":"Cervello","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellimm.2014.11.003_b0135","first-page":"81","article-title":"Anti-angiogenic therapy for HCC","volume":"58","author":"Dufour","year":"2012","journal-title":"Minerva Gastroenterol. Dietol."},{"key":"10.1016\/j.cellimm.2014.11.003_b0140","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/CJI.0b013e3181cc266b","article-title":"Dendritic cells generated in clinical grade bags strongly differ in immune functionality when compared with classical DCs generated in plates","volume":"33","author":"Rouas","year":"2010","journal-title":"J. Immunother."},{"key":"10.1016\/j.cellimm.2014.11.003_b0145","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3727\/096368909X12483162196962","article-title":"Recent advances of dendritic cells (DCs)-based immunotherapy for malignant gliomas","volume":"18","author":"Cho","year":"2009","journal-title":"Cell Transplant."},{"key":"10.1016\/j.cellimm.2014.11.003_b0150","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-3083.2008.02083.x","article-title":"Appropriate timing of CD40 ligation for RNA-Pulsed DCs to induce antitumor immunity","volume":"67","author":"Miura","year":"2008","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.cellimm.2014.11.003_b0155","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bbamcr.2013.01.009","article-title":"FAT10ylation as a signal for proteasomal degradation","volume":"1843","author":"Schmidtke","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cellimm.2014.11.003_b0160","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ncomms1752","article-title":"FAT10 and NUB1L bind to the VWA domain of Rpn10 and Rpn1 to enable proteasome-mediated proteolysis","volume":"3","author":"Rani","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellimm.2014.11.003_b0165","doi-asserted-by":"crossref","first-page":"29594","DOI":"10.1074\/jbc.M111.261032","article-title":"FAT10 protein binds to polyglutamine proteins and modulates their solubility","volume":"286","author":"Nagashima","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2014.11.003_b0170","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.febslet.2009.01.006","article-title":"Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L","volume":"583","author":"Schmidtke","year":"2009","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cellimm.2014.11.003_b0175","doi-asserted-by":"crossref","first-page":"20045","DOI":"10.1074\/jbc.M603063200","article-title":"The UBA domains of NUB1L are required for binding but not for accelerated degradation of the ubiquitin-like modifier FAT10","volume":"281","author":"Schmidtke","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2014.11.003_b0180","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.yexmp.2011.07.004","article-title":"The role of innate immunity in the pathogenesis of preneoplasia in drug-induced chronic hepatitis based on a mouse model","volume":"91","author":"French","year":"2011","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.cellimm.2014.11.003_b0185","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.3748\/wjg.15.2228","article-title":"FAT10 level in human gastric cancer and its relation with mutant p53 level, lymph node metastasis and TNM staging","volume":"15","author":"Ji","year":"2009","journal-title":"World J. Gastroenterol."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000887491400166X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000887491400166X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T22:51:08Z","timestamp":1757803868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000887491400166X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S000887491400166X"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2014.11.003","relation":{},"ISSN":["0008-8749"],"issn-type":[{"type":"print","value":"0008-8749"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction of anti-tumor immunity by dendritic cells transduced with FAT10 recombinant adenovirus in mice","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2014.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}